Thankyou thankyou thankyou.
Again, board have listened to shareholders and made it right. The comparisons of cost are exactly what was needed.
Also the price assumptions are very surprising to me. The price of $446USD for year 1 is criminal.
Could the smug little turds peddling their concerns please come back? I'd like to have a word.
- Forums
- ASX - By Stock
- FFX
- Ann: Presentation to Shareholder Meeting
Ann: Presentation to Shareholder Meeting, page-19
-
- There are more pages in this discussion • 329 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online